Healthcare / Health Information ServicesLSE
$187.30
+0.30 (+0.16%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $2.4M · quality 48.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$204M
P/E
15.6x
↓EV/EBITDA
705.4x
↑ROE
1.0%
↑Gross Margin
31.5%
↓Debt/Equity
0.13
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+67.4%
FCF CAGR
—
FCF margin
-1.0%
FCF / Net income
-0.64x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $105.0M · net income $1.7M · FCF $-1.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $105.0M | $105.0M | $110.9M | $115.3M | $22.4M |
| Net Income | $1.7M | $1.7M | $-1.1M | $1.6M | $-246000.00 |
| EBITDA | $13.7M | $13.7M | $10.1M | $11.1M | $1.7M |
| EPS | 0.03 | 0.03 | -0.01 | 0.02 | -0.00 |
| Gross Margin | 31.5% | 31.5% | 32.9% | 32.0% | 35.9% |
| Operating Margin | 6.8% | 6.8% | 6.5% | 9.4% | 3.3% |
| Net Margin | 1.6% | 1.6% | -1.0% | 1.4% | -1.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.13 | 0.13 | 0.45 | 0.45 | 0.27 |
| Current Ratio | 1.82 | 1.82 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.1M | $-1.1M | $10.0M | $2.4M | $-1.6M |
| Returns | |||||
| ROE | 1.0% | 1.0% | -0.8% | 1.2% | -0.2% |
| Valuation | |||||
| P/E | 15.61 | 15.61 | — | — | — |
| EV/EBITDA | 705.39 | 705.39 | — | — | — |
| P/B | 57.24 | 57.24 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -5.3% | -5.3% | -3.9% | 415.3% | — |
| EPS Growth | 345.9% | 345.9% | -168.0% | 747.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
721.3%
EPS terminal req.
$16.62
Spread vs growth
-375.4%
5Y implied EPS CAGR
267.5%
EPS terminal req.
$20.11
Spread vs growth
78.4%
10Y implied EPS CAGR
101.1%
EPS terminal req.
$32.39
Spread vs growth
244.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-2.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → 0.03
Residual
-2.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.